Sompo Holdings Valuation

Is ANK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ANK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ANK (€24.4) is trading below our estimate of fair value (€53.65)

Significantly Below Fair Value: ANK is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ANK?

Key metric: As ANK is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ANK. This is calculated by dividing ANK's market cap by their current earnings.
What is ANK's PE Ratio?
PE Ratio8.6x
EarningsJP¥436.05b
Market CapJP¥3.79t

Price to Earnings Ratio vs Peers

How does ANK's PE Ratio compare to its peers?

The above table shows the PE ratio for ANK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average11.8x
TLX Talanx
10.9x5.0%€20.6b
HNR1 Hannover Rück
13.2x5.7%€29.8b
MUV2 Münchener Rückversicherungs-Gesellschaft in München
11.2x2.9%€64.1b
ALV Allianz
11.9x5.9%€112.5b
ANK Sompo Holdings
8.5x2.5%€3.7t

Price-To-Earnings vs Peers: ANK is good value based on its Price-To-Earnings Ratio (8.5x) compared to the peer average (11.8x).


Price to Earnings Ratio vs Industry

How does ANK's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
ANK 8.6xIndustry Avg. 11.9xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ANK is good value based on its Price-To-Earnings Ratio (8.5x) compared to the European Insurance industry average (11.9x).


Price to Earnings Ratio vs Fair Ratio

What is ANK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ANK PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio8.6x
Fair PE Ratio7.7x

Price-To-Earnings vs Fair Ratio: ANK is expensive based on its Price-To-Earnings Ratio (8.5x) compared to the estimated Fair Price-To-Earnings Ratio (7.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ANK forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€24.40
€24.09
-1.3%
14.6%€31.91€18.31n/a11
Nov ’25€19.40
€24.25
+25.0%
14.6%€32.13€18.43n/a11
Oct ’25€19.50
€25.41
+30.3%
14.9%€33.34€19.13n/a11
Sep ’25€21.40
€23.92
+11.8%
13.0%€31.33€20.36n/a10
Aug ’25€19.30
€23.92
+24.0%
13.0%€31.33€20.36n/a10
Jul ’25€19.80
€21.77
+10.0%
15.5%€30.85€17.70n/a10
Jun ’25€19.30
€18.98
-1.7%
12.6%€22.86€14.65n/a10
May ’25€18.20
€18.99
+4.4%
11.7%€23.09€14.80n/a10
Apr ’25€19.30
€19.05
-1.3%
13.6%€24.01€14.83n/a11
Mar ’25€18.17
€16.49
-9.3%
14.4%€21.51€13.11n/a11
Feb ’25€15.87
€15.77
-0.6%
9.5%€18.90€13.44n/a11
Jan ’25€14.60
€15.24
+4.4%
7.3%€17.39€13.57n/a12
Dec ’24€14.00
€14.39
+2.8%
7.8%€16.91€12.58n/a13
Nov ’24€13.67
€14.53
+6.3%
8.4%€17.24€12.82€19.4013
Oct ’24€13.47
€14.50
+7.7%
9.5%€17.35€12.91€19.5012
Sep ’24€13.53
€14.75
+9.0%
8.8%€17.52€13.03€21.4012
Aug ’24€13.00
€14.81
+13.9%
9.1%€17.69€13.16€19.3011
Jul ’24€13.53
€14.08
+4.0%
8.0%€16.05€12.28€19.8011
Jun ’24€12.87
€14.07
+9.4%
5.2%€15.27€12.89€19.3010
May ’24€12.47
€14.77
+18.5%
8.8%€16.94€12.65€18.2013
Apr ’24€12.07
€15.11
+25.2%
8.3%€17.17€13.17€19.3011
Mar ’24€13.33
€14.73
+10.5%
7.9%€16.83€12.91€18.1711
Feb ’24€13.13
€15.06
+14.6%
7.5%€17.20€13.19€15.8712
Jan ’24€13.80
€15.42
+11.7%
9.4%€18.75€13.29€14.6014
Dec ’23€13.60
€15.39
+13.2%
9.6%€18.49€13.11€14.0014
Nov ’23€14.00
€14.95
+6.8%
9.7%€17.99€12.75€13.6714

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies